Upcoming Studies

BGOG-ov-29

A randomized, double blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab.

Learn More ->

BGOG-ov-39

A Phase III, multicenter, randomized, Study of Atezolizumab Versus Placebo in combination with Paclitaxel, carboplatin, and Bevacizumab for patients with Newly diagnosed stage III/IV ovarian, fallopian tube, or primary peritoneal cancer

Learn More ->

BGOG-en-5

A Randomized Phase III Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer.

Learn More ->

BGOG-cx-2B

A prospective observational trial on sentinel lymph node biopsy in patients with early stage cervical cancer.

Learn More ->

BGOG-cx-101

Prospective randomized Phase II trial comparing doxorubicin alone versus atezolizumab alone versus doxorubicin and atezolizumab in recurrent cervical cancer.

Learn More ->